Suppr超能文献

鲍曼不动杆菌脂多糖合成途径中LpxA的结构测定。

Structure determination of LpxA from the lipopolysaccharide-synthesis pathway of Acinetobacter baumannii.

作者信息

Badger John, Chie-Leon Barbara, Logan Cheyenne, Sridhar Vandana, Sankaran Banumathi, Zwart Peter H, Nienaber Vicki

机构信息

Zenobia Therapeutics Inc., 505 Coast Boulevard South, Suite 111, La Jolla, CA 92037, USA.

出版信息

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2012 Dec 1;68(Pt 12):1477-81. doi: 10.1107/S174430911204571X. Epub 2012 Nov 28.

Abstract

Acinetobacter baumannii is a Gram-negative pathogenic bacterium which is resistant to most currently available antibiotics and that poses a significant health threat to hospital patients. LpxA is a key enzyme in the biosynthetic pathway of the lipopolysaccharides that are components of the bacterial outer membrane. It is a potential target for antibacterial agents that might be used to fight A. baumannii infections. This paper describes the structure determination of the apo form of LpxA in space groups P2(1)2(1)2(1) and P6(3). These crystal forms contained three and one protein molecules in the asymmetric unit and diffracted to 1.8 and 1.4 Å resolution, respectively. A comparison of the conformations of the independent protein monomers within and between the two crystal asymmetric units revealed very little structural variation across this set of structures. In the P6(3) crystal form the enzymatic site is exposed and is available for the introduction of small molecules of the type used in fragment-based drug discovery and structure-based lead optimization.

摘要

鲍曼不动杆菌是一种革兰氏阴性致病细菌,对目前大多数可用抗生素具有抗性,对医院患者构成重大健康威胁。LpxA是脂多糖生物合成途径中的关键酶,脂多糖是细菌外膜的组成成分。它是可能用于对抗鲍曼不动杆菌感染的抗菌剂的潜在靶点。本文描述了在空间群P2(1)2(1)2(1)和P6(3)中LpxA无配体形式的结构测定。这些晶体形式在不对称单元中分别包含三个和一个蛋白质分子,衍射分辨率分别为1.8 Å和1.4 Å。对两个晶体不对称单元内和之间独立蛋白质单体的构象进行比较,发现在这组结构中结构变化很小。在P6(3)晶体形式中,酶活性位点暴露,可用于引入基于片段的药物发现和基于结构的先导化合物优化中使用的小分子类型。

相似文献

1
Structure determination of LpxA from the lipopolysaccharide-synthesis pathway of Acinetobacter baumannii.
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2012 Dec 1;68(Pt 12):1477-81. doi: 10.1107/S174430911204571X. Epub 2012 Nov 28.
2
Structure determination of LpxD from the lipopolysaccharide-synthesis pathway of Acinetobacter baumannii.
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2013 Jan 1;69(Pt 1):6-9. doi: 10.1107/S1744309112048890. Epub 2012 Dec 25.
3
Crystal structure of the Acinetobacter baumannii outer membrane protein Omp33.
Acta Crystallogr D Struct Biol. 2018 Sep 1;74(Pt 9):852-860. doi: 10.1107/S205979831800904X. Epub 2018 Sep 3.
4
Structural Insights into Outer Membrane Permeability of Acinetobacter baumannii.
Structure. 2016 Feb 2;24(2):221-31. doi: 10.1016/j.str.2015.12.009. Epub 2016 Jan 21.
5
Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production.
Antimicrob Agents Chemother. 2010 Dec;54(12):4971-7. doi: 10.1128/AAC.00834-10. Epub 2010 Sep 20.
6
Expression, crystallization and preliminary X-ray crystallographic analysis of cystathionine β-lyase from Acinetobacter baumannii OXA-23.
Acta Crystallogr F Struct Biol Commun. 2014 Oct;70(Pt 10):1368-71. doi: 10.1107/S2053230X14017981. Epub 2014 Sep 25.
9
Small-Molecule Transport by CarO, an Abundant Eight-Stranded β-Barrel Outer Membrane Protein from Acinetobacter baumannii.
J Mol Biol. 2015 Jul 17;427(14):2329-39. doi: 10.1016/j.jmb.2015.03.016. Epub 2015 Apr 3.
10
Purification, crystallization and preliminary X-ray crystallographic analysis of diaminopimelate epimerase from Acinetobacter baumannii.
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2013 Jan 1;69(Pt 1):42-4. doi: 10.1107/S1744309112048506. Epub 2012 Dec 20.

引用本文的文献

1
Identification and prioritization of potential therapeutic molecules against LpxA from - A computational study.
Curr Res Struct Biol. 2023 Feb 15;5:100096. doi: 10.1016/j.crstbi.2023.100096. eCollection 2023.
2
Emergence of Colistin-Resistant in China.
Antibiotics (Basel). 2022 Nov 24;11(12):1693. doi: 10.3390/antibiotics11121693.
3
Structure-Based Virtual Screening of LpxA Inhibitors Using Pharmacophore-Based Approach.
Biomolecules. 2020 Feb 10;10(2):266. doi: 10.3390/biom10020266.
5
Structures of Bacteroides fragilis uridine 5'-diphosphate-N-acetylglucosamine (UDP-GlcNAc) acyltransferase (BfLpxA).
Acta Crystallogr D Biol Crystallogr. 2015 May;71(Pt 5):1068-76. doi: 10.1107/S1399004715003326. Epub 2015 Apr 24.

本文引用的文献

1
Processing of X-ray diffraction data collected in oscillation mode.
Methods Enzymol. 1997;276:307-26. doi: 10.1016/S0076-6879(97)76066-X.
2
Application of SBDD to the discovery of new antibacterial drugs.
Methods Mol Biol. 2012;841:291-319. doi: 10.1007/978-1-61779-520-6_13.
3
REFMAC5 for the refinement of macromolecular crystal structures.
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):355-67. doi: 10.1107/S0907444911001314. Epub 2011 Mar 18.
4
Multidrug resistant Acinetobacter baumannii: a descriptive study in a city hospital.
BMC Infect Dis. 2010 Jul 7;10:196. doi: 10.1186/1471-2334-10-196.
5
Phaser crystallographic software.
J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674. doi: 10.1107/S0021889807021206. Epub 2007 Jul 13.
7
Drug treatment for multidrug-resistant Acinetobacter baumannii infections.
Future Microbiol. 2008 Dec;3(6):649-60. doi: 10.2217/17460913.3.6.649.
8
Acinetobacter infections: a growing threat for critically ill patients.
Epidemiol Infect. 2008 Aug;136(8):1009-19. doi: 10.1017/S0950268807009478. Epub 2007 Sep 25.
9
Structural basis for the acyl chain selectivity and mechanism of UDP-N-acetylglucosamine acyltransferase.
Proc Natl Acad Sci U S A. 2007 Aug 21;104(34):13543-50. doi: 10.1073/pnas.0705833104. Epub 2007 Aug 13.
10
Nucleotide substrate recognition by UDP-N-acetylglucosamine acyltransferase (LpxA) in the first step of lipid A biosynthesis.
J Mol Biol. 2007 Jun 1;369(2):305-12. doi: 10.1016/j.jmb.2007.03.039. Epub 2007 Mar 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验